Scleroderma-related Lung Fibrosis
📧 Sign up to get email alerts when something new happens for Scleroderma-related Lung Fibrosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-02-20Clinical Trial Update: A Trial to Evaluate the Safety of Long Term Treatment With Nintedanib in Patients With Scleroderma Related Lung Fibrosis [Phase 3]
A Phase 3 trial evaluating the long-term safety of nintedanib in scleroderma-related lung fibrosis has completed and posted results in 2024.
-
CLINICAL_TRIALS trial_result · 2019-12-13Clinical Trial Update: A Trial to Compare Nintedanib With Placebo for Patients With Scleroderma Related Lung Fibrosis [Phase 3]
Phase 3 trial comparing nintedanib to placebo in scleroderma-related lung fibrosis completed; results posted in 2019.